Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Next-generation Sequencing03:00

Next-generation Sequencing

98.8K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
98.8K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.6K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.6K
Uncertainty in Measurement: Accuracy and Precision03:37

Uncertainty in Measurement: Accuracy and Precision

104.1K
Scientists typically make repeated measurements of a quantity to ensure the quality of their findings and to evaluate both the precision and the accuracy of their results. Measurements are said to be precise if they yield very similar results when repeated in the same manner. A measurement is considered accurate if it yields a result that is very close to the true or the accepted value. Precise values agree with each other; accurate values agree with a true value. 
104.1K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

429
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
429

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial.

Alzheimer's & dementia (New York, N. Y.)·2026
Same author

Race-Neutral FRAX without BMD outperforms FRAX without BMD in a multiethnic cohort with Diabetes or Hypertension.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Same author

2D Ultrasound Elasticity Imaging of Abdominal Aortic Aneurysms Using Deep Neural Networks.

IEEE transactions on computational imaging·2026
Same author

Toward Patient-Specific Partial Point Cloud to Surface Completion for Pre to Intra-operative Registration in Image-Guided Liver Interventions.

Medical Image Understanding and Analysis. Medical Image Understanding and Analysis (Conference)·2026
Same author

Evaluation of Intra-operative Patient-specific Methods for Point Cloud Completion for Minimally Invasive Liver Interventions.

Proceedings of SPIE--the International Society for Optical Engineering·2026
Same author

Investigating the Domain Adaptability of General-Purpose Foundation Models for Left Atrium Segmentation from MR Images.

Functional imaging and modeling of the heart : ... International Workshop, FIMH ..., proceedings. FIMH (Conference)·2026

Related Experiment Video

Updated: Feb 10, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K

Clinical trials for precision oncology using next-generation sequencing.

Richard Simon1, Eric Polley2

  • 1Biometric Research Branch, National Cancer Institute, 9609 Medical Center Drive, Room 5W110, MSC 9735, Bethesda, MD 20892, USA. rsimon@nih.gov .

Personalized Medicine
|May 16, 2018
PubMed
Summary

Genomic heterogeneity in cancer impacts drug development. Understanding tumor genomics and pathway crosstalk is crucial for effective cancer therapeutics and personalized diagnostics.

Keywords:
cancer biomarkercancer clinical trialnext-generation sequencingpersonalized medicineprecision medicine

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

424

Related Experiment Videos

Last Updated: Feb 10, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

424

Area of Science:

  • Oncology
  • Genomics
  • Molecular Diagnostics

Background:

  • Human cancers exhibit significant genomic heterogeneity, influencing therapeutic development and diagnostic strategies.
  • Targeted cancer therapies and companion diagnostics are increasingly focused on specific tumor genetic alterations.
  • The oncology landscape is shifting towards stratified approaches, including enrichment Phase III trials.

Purpose of the Study:

  • To review the challenges and ongoing clinical studies in translating tumor genomics into clinical oncology practice.
  • To highlight the need for a deeper understanding of signaling pathway crosstalk for improved cancer treatment outcomes.
  • To emphasize the potential of early-phase clinical trials with comprehensive genomic characterization for treatment matching.

Main Methods:

  • Review of current challenges in clinical genomics implementation.
  • Analysis of clinical studies focused on translating genomic data into oncology.
  • Discussion of strategies for effective therapeutic matching based on genomic alterations.

Main Results:

  • Single-agent targeted therapies for metastatic disease offer limited patient benefit.
  • Substantial gains necessitate understanding pathway crosstalk, drug combinations, and early-stage treatment.
  • Early-phase trials with genome-wide tumor characterization are vital for generating data on therapeutic matching.

Conclusions:

  • Translating tumor genomics into clinical oncology faces practical hurdles.
  • Effective cancer treatment requires a move beyond single-agent therapies to combination strategies informed by comprehensive genomic data.
  • Ongoing clinical studies aim to overcome these challenges and integrate genomics into routine cancer care.